Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02918032 · ClinicalTrials.gov registry record
International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Related Diseases
A clinical trial of Neutral Lipid Storage Disease, sponsored by Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan.
- Recruiting
- Registry status
- 120
- Enrollment target
- 15
- Study locations
NCT02918032 is a study of Neutral Lipid Storage Disease that is actively recruiting participants, run by Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan. The registered enrollment target is 120 participants. The trial reports 15 study locations across 14 states.
The verdict
NCT02918032, a study of Neutral Lipid Storage Disease, is actively recruiting participants, sponsored by Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 15
- Study locations
Study Summary
This study aims to understand the state of onset of NLSD(neutral lipid storage disease) / TGCV(triglyceride deposit cardiovasculopathy) worldwide, background information of affected patients, and natural history of the disease, as well as exploring the prognostic factors and assessing the efficacy of disease-specific treatment.
Conditions Studied
Study Locations (15)
Lazio
- Sapienza University of Rome - Rome
- A.C.O. San Filippo Neri Hospital - Rome
California
- Stanford University - Stanford
New York
- Columbia University - New York
Styria
- University of Graz - Graz
Beijing Municipality
- Peking University First Hospital - Beijing
Paris
- Pitié-Salpêtrière Hospital - Paris
Bavaria
- Ludwig-Maximilians University - Munich
Lombardy
- Catholic University - Milan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2014-01 |
| Est. Completion | 2028-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02918032
The ClinicalTrials.gov registry entry for NCT02918032 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neutral Lipid Storage Disease appearing as the primary indexed condition, and to 0 interventions.
NCT02918032 reports 15 study locations spanning 14 distinct geographic areas - top geographies include Lazio, California, New York.
Frequently Asked Questions
What is clinical trial NCT02918032 about?
NCT02918032 is a clinical study titled "International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Related Diseases". This study aims to understand the state of onset of NLSD(neutral lipid storage disease) / TGCV(triglyceride deposit cardiovasculopathy) worldwide, background information of affected patients, and natural history of the disease, as well as exploring the prognostic factors and assessing the efficacy o...
What is the current status of trial NCT02918032?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2014-01. Estimated completion is 2028-03-31.
What conditions does trial NCT02918032 study?
This clinical trial studies the following conditions: Neutral Lipid Storage Disease.
Who is sponsoring clinical trial NCT02918032?
This trial is sponsored by Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02918032 being conducted?
This trial has 15 study locations across California, New York, Styria, Beijing Municipality, Paris. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.